Q4 2021 Holdings
Filed 2022-02-11 | 152 holdings | $587.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $5.9K | 250,000 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $6.0K | 250,000 | 0.0% |
| Evelo Biosciences Inc | COM | 299734103 | $6.1K | 1,000,000 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $6.2K | 1,300,000 | 0.0% |
| Sana Biotechnology Inc(SANA) | COM | 799566104 | $6.2K | 400,000 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $6.2K | 525,000 | 0.0% |
| VOR Biopharma Inc | COM | 929033108 | $6.4K | 550,000 | 0.0% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $6.5K | 400,000 | 0.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $6.7K | 700,000 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $6.8K | 200,000 | 0.0% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $7.2K | 450,000 | 0.0% |
| Omega Alpha Spac | CL A | G6749V107 | $7.3K | 750,000 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $7.4K | 450,000 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $7.5K | 1,200,000 | 0.0% |
| Harpoon Therapeutics Inc | COM | 41358P106 | $7.6K | 1,000,000 | 0.0% |
| Instil BIO Inc | COM | 45783C101 | $7.7K | 450,000 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $8.0K | 500,000 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $8.0K | 2,500,000 | 0.0% |
| Nanobiotix SA(NBTX) | SPONSORED ADS | 63009J107 | $8.1K | 1,000,000 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $8.2K | 593,030 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $8.6K | 400,000 | 0.0% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $8.7K | 700,000 | 0.0% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $9.6K | 750,000 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $9.8K | 3,000,000 | 0.0% |
| Sage Therapeutics Inc(SG7)Call | COM | 78667J108 | $10.6K | 250,000 | 0.0% |
| Exscientia PLC | ADS | 30223G102 | $10.9K | 550,000 | 0.0% |
| Achilles Therapeutics PLC(698) | SPONSORED ADS | 00449L102 | $11.3K | 2,255,375 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $11.9K | 1,000,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $11.9K | 250,000 | 0.0% |
| Oatly Group AB | SPONSORED ADS | 67421J108 | $11.9K | 1,500,000 | 0.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $12.1K | 1,040,882 | 0.0% |
| Leap Therapeutics Inc | COM | 52187K101 | $13.0K | 4,000,000 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $13.0K | 4,000,000 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $14.0K | 600,000 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $14.2K | 1,000,000 | 0.0% |
| SQZ Biotechnologies Co(SQZB) | COM | 78472W104 | $14.3K | 1,606,309 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $14.7K | 1,050,000 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $14.7K | 400,000 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $14.8K | 700,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $15.2K | 800,000 | 0.0% |
| Intel Corp(INTC)Call | COM | 458140100 | $15.5K | 300,000 | 0.0% |
| Aptinyx Inc | COM | 03836N103 | $16.3K | 6,116,493 | 0.0% |
| Novagold RES Inc(NG) | COM NEW | 66987E206 | $17.8K | 2,600,000 | 0.0% |
| Ikena Oncology Inc | COM | 45175G108 | $19.4K | 1,549,513 | 0.0% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $19.4K | 2,152,291 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $19.9K | 2,814,191 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $20.9K | 6,500,000 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $21.0K | 1,542,954 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX)Call | COM | 92532F100 | $22.0K | 100,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $23.0K | 750,000 | 0.0% |